# TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

> **NCT02327351** · PHASE2,PHASE3 · COMPLETED · sponsor: **Federal Research Institute of Pediatric Hematology, Oncology and Immunology** · enrollment: 98 (actual)

## Conditions studied

- Primary Immune Deficiency Disorder
- Hematopoietic Stem Cell Transplantation

## Interventions

- **OTHER:** Biological: TCR alfa beta T cell depletion

## Key facts

- **NCT ID:** NCT02327351
- **Lead sponsor:** Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2017-12
- **Final completion:** 2018-06
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02327351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02327351, "TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02327351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*